The Triple-Agonist Frontier: Why Experts Are Warning Against the Rush for Retatrutide
Nana Wu
The landscape of obesity medicine is undergoing a seismic shift. In just a few short years, we have moved from a lack of effective pharmacological interventions to a "golden age"…
